Bloomberg News (5/18, Gale) reported, “The drug ketamine relieved symptoms of hard-to-treat depression within a day of treatment, in the largest study yet of the drug’s potential use for depression.” In the study of “72 people whose depression hadn’t responded to at least two antidepressants, patients taking ketamine were twice as likely to report improvement than those on a placebo.” The researchers from Baylor College of Medicine in Houston and Mount Sinai School of Medicine in New York “will present the findings at the meeting of the American Psychiatric Association,” which started Saturday in San Francisco.
Related Links:
— “Club-Drug Ketamine Relieves Depression in Largest Patient Study, “Jason Gale, Bloomberg News, May 18, 2013.